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Reproducing extracellular matrix topographical cues, such as those present within acellular dermal
matrix (ADM), in synthetic implant surfaces, may augment cellular responses, independent of surface
chemistry. This could lead to enhanced implant integration and performance while reducing
complications. In this work, the hierarchical micro and nanoscale features of ADM were accurately and
reproducibly replicated in polydimethylsiloxane (PDMS), using an innovative maskless 3D grayscale
fabrication process not previously reported. Human breast derived ﬁbroblasts (n ¼ 5) were cultured on
PDMS surfaces and compared to commercially available smooth and textured silicone implant surfaces,
for up to one week. Cell attachment, proliferation and cytotoxicity, in addition to immunoﬂuorescence
staining, SEM imaging, qRT-PCR and cytokine array were performed. ADM PDMS surfaces promoted cell
adhesion, proliferation and survival (p¼< 0.05), in addition to increased focal contact formation and
spread ﬁbroblast morphology when compared to commercially available implant surfaces. PCNA,
vinculin and collagen 1 were up-regulated in ﬁbroblasts on biomimetic surfaces while IL8, TNFa, TGFb1
and HSP60 were down-regulated (p¼< 0.05). A reduced inﬂammatory cytokine response was also
observed (p¼< 0.05). This study represents a novel approach to the development of functionalised
biomimetic prosthetic implant surfaces which were demonstrated to signiﬁcantly attenuate the acute
in vitro foreign body reaction to silicone.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Surgical implants provide a diverse variety of site-speciﬁc tissue
replacements for a number of functions, which are available to the
practising surgeon. Common examples in use today include breast
implants, dental implants, nerve conduits, vascular implants and
orthopaedic implants [1]. The increasing demand for synthetically
engineered body implants is a result of an ageing population and
the associated tissue degeneration and malignancy [2]. This trend
will continue until tissue regeneration techniques utilising
autologous mesenchymal stem cells to engineer tissue-speciﬁc
replacements becomes perfected and available to routine clinicalBiotechnology, University of
, UK. Tel.: þ44 161 306 5177.
(A. Bayat).
r Ltd. This is an open access articlepractice. The biomaterials industry is expected to be worth $58.1
billion in 2014 [3] as medical devices such as breast implants are
being increasingly required, with 385,813 breast augmentations/
reconstructions (72% silicone implants) performed in the United
States alone in 2013, up 2% from 2012 to 32% from 2000 [4].
However, current commercially available silicone mammary
implants are not without their complications. For instance, silicone
mammary implant surfaces suffer from signiﬁcant limitation due to
the formation of a constrictive ﬁbrotic capsule post-implantation,
known as capsular contracture, which results in ﬁrmness,
deformity and pain in addition to device failure [5]. Capsular
contracture formation remains the most common complication
associated with silicone mammary implants, with rates ranging
between 14.8 and 20.5% [6].
The exact pathoetiology of breast implant surface-related
capsular contracture formation remains unclear, however, thereunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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rial infection and radiotherapy pre or post-implantation, while sub-
muscular placement and importantly, textured as opposed to
smooth implants, can reduce contracture risk [7]. In addition to
currently practised methods of limiting rates of capsular contrac-
ture formation through minimising bacterial infection around the
implant (exogenous hypothesis), an alternative approach to this
clinically signiﬁcant complication is necessary to reduce the over-
exaggerated foreign body reaction to the implant (endogenous
hypothesis) [8].
Current commercially available silicone breast implants were
fundamentally designed in the 1960's and the elastomeric implant
shell (the site of the tissue/implant interface) is described as being
either ‘smooth’ or ‘textured’ [9,10]. Textured implants are macro-
scopically rough surfaces formed either of nodular features or
cuboid shaped pits, which are hundreds of microns large [11].
However, current silicone breast implants are intrinsically limited
in their performance as the elastomeric shells (surfaces) were not
designed with consideration of the mechanisms which promote
favourable host response being a primary objective of the implants'
function and rather they evolved through “trial and error optimi-
zation” [12], resulting in minimal advancement in implant perfor-
mance. Conversely, due to the availability of advanced fabrication
techniques and increased understanding of the variables which
inﬂuence host-response at the cell-implant surface interface,
medical devices manufactured today should aim to be non-toxic
and non-immunogenic, whilst performing an active role in host
response [13,14].
Micrometric and nanometric surface topographies inﬂuence cell
attachment, proliferation, migration and differentiation in
numerous cell types and on various substrates, both in vitro and
in vivo [15e20]. It has been suggested that initial implant cell
attachment and subsequent cytokine releasemay dictate the extent
and impact of the foreign body reaction and clinical outcome
through cell mechanotransduction and signal transduction mech-
anisms, which mediate cytokine/chemokine release and extracel-
lular matrix (ECM) deposition [21e23]. This is the rationale behind
the current tendency to use acellular dermal matrix (ADM) in
implant-based breast augmentation/reconstruction. It is thought
that ADM, in addition to providing inframammary support to the
implant, provides peri-implant cells and tissues with a familiar
biological microenvironment, containing complex nano and micro-
topographical cues which delivers stimulus for speciﬁc and
directed cell response [24e26]. The result is diminished foreign
body reaction to the implant and reduced capsular contracture
formation [27].
Our intuitive aim here was to design and fabricate a novel bio-
mimetic silicone surface, acellular dermal matrix poly-
dimethylsiloxane fabricated (ADM PDMS F), through reproduction
of the complex hierarchical, nano and micro-scale topography of
ADM using an innovative maskless 3D grayscale lithography
fabrication process, not reported to date. This creative approach to
implant surface design combines our understanding of the poten-
tial positive effects of micro and nanoscale topographies on cell
function with the unique and inherent beneﬁts of biomimetic
structures. A silicone surface prepared using a direct casting (soft
lithography) technique, acellular dermal matrix poly-
dimethylsiloxane cast (ADM PDMS C), was also created to use as
further validation.
Therefore, it is proposed that the biomimetic topographical cues
of ADM in silicone may mitigate the acute in vitro foreign body
response of breast-derived ﬁbroblasts (BDFs) in comparison to
commercially available smooth and textured silicone implant sur-
faces. For validation, a comprehensive in vitro biological evaluation
of BDF cell function on respective surfaces through analysis of cellattachment, proliferation, morphology, gene expression and cyto-
kine secretion was performed, to elucidate whether early BDF
response to silicone surfaces could be positively altered through
biomimetic topography.
2. Materials and methods
Tissue samples used in this study were obtained by the Plastics and Recon-
structive Surgery Research (PRSR) Skin and Tissue Bank (NorthWest Research Ethics
Committee, Ethics code e 11/NW/0683). Patients were recruited and samples ob-
tained following informed consent prior to elective breast reduction (to obtain skin
and breast tissue). Patient demographics are found in Supplementary Table S1.
Samples were anonymised and coded prior to use. In this work, two poly-
dimethylsiloxane (PDMS) surfaces were fabricated, characterised and biologically
evaluated; acellular dermal matrix polydimethylsiloxane fabricated surface (ADM
PDMS F) and acellular dermal matrix polydimethylsiloxane cast surface (ADM PDMS
C).
2.1. Collection of skin samples and tissue decellularisation protocol
Normal skin (n ¼ 3) was collected from patients undergoing breast reduction
surgery and stored in growth media containing Dulbeccos Modiﬁed Eagle Medium
(DMEM) (Sigma-Aldrich, UK) supplementedwith 10% fetal bovine serum (FBS) (PAA,
Austria), penicillin (100 units/ml), streptomycin (100 units/ml) and L-glutamine
(2 mM) (PAA Austria) while transported to laboratory. The skin was washed thor-
oughly in sterile phosphate buffered saline (PBS) supplemented with penicillin (100
units/ml) and streptomycin (100 units/ml), to remove any remaining blood, before
hair and subcutaneous fat was removed. The decellularisation protocol followed is
outlined in Hogg (2013) [28] and an exhaustive list of reagents used and exact
protocol can be found in Supplementary Table S2 and S3, in addition to Hogg (2013)
[28]. Brieﬂy, the protocol involved moving the tissue through a succession of re-
agents, beginning with removal of the epidermis, followed by tissue disinfection in
peracetic acid, digestion of cellular components in a hypotonic buffer, a detergent
wash to remove cellular debris and removal of nuclear contents [28].
2.2. Immunohistochemistry and haematoxylin and eosin staining of ADM
Immunoperoxidase staining was performed for collagen type IV, collagen type
VII and laminin V to conﬁrm the presence of an intact basement membrane (BM),
using Novacastra™ Novolink™ Polymer Detection System (Leica Biosystems, UK),
following manufacturer's instructions. Brieﬂy, formalin ﬁxed, parafﬁn embedded
tissue samples were serially sectioned into 5 mm thickness, mounted onto charged
slides (Thermo Scientiﬁc, USA) and left to dry overnight. Sections were then
deparafﬁnised, rehydrated and antigen retrieved in sodium citrate buffer (Ph 6 and
60 C for 1 h). Endogenous peroxidase and non-speciﬁc protein binding was blocked
and the section treated with primary antibodies overnight at 4 C (Supplementary
Table S4). The sections were then further incubated with Post Primary Block and
then with Novalink Polymer before proteins were ﬁnally detected using DAB chro-
mogen substrate buffer for peroxidase detection and counterstained with haema-
toxylin. In addition, sections were stained with haematoxylin and eosin (H&E), to
ensure morphology of tissue was not altered by decellularisation protocol, using
standard laboratory protocol as previously described [29]. All sections were imaged
on an upright Olympus Microscope (BX51, Olympus, UK).
2.3. Fabrication of ADM PDMS F
2.3.1. Characterising ADM using atomic force microscopy (AFM)
ADM samples were placed basement membrane (BM) side up onto microscope
slides and allowed to slowly air dry at 4 C for 24 h. ADMwas imaged using a Bruker
Dimension Icon® Atomic Force Microscope (AFM) (Bruker, UK). Samples were
imaged using ScanAsyst™ Air probes (Bruker, UK) (silicon nitride, nominal k¼ 0.4 N/
m) and conducted in ScanAsyst™mode. Peak Force Tapping™ (PFT) amplitude was
150e100 nm, and PFT frequency was 1 kHz. Scan rate was 0.5 Hz. A large, intact area
of ADM (500 um) was imaged through obtaining numerous 90  90 mm2 AFM scans
using offsets in the X and Y direction (Supplementary Fig. S1A). Scans were per-
formed in at least 3 different areas of the ADM sample and on 3 different patient
samples.
2.3.2. Creating a grayscale ADM pattern for exposure
An ADM montage was created using the stitching feature within Mountain
Maps® 7 imaging software (Digital Surf©, France) to stitch together numerous,
adjacent raw 90  90 mm2 AFM images of ADM. The montage was produced using X
and Y offsets and similarities in height at the image edge to correctly align images,
thereby forming a large intact area of ADM without leaving stitch lines
(Supplementary Fig. S1CeD). The ADMmontagewas converted to an 8-bit grayscale
image, consisting of 256 grayscale levels (Supplementary Fig. S1BeD), using the
open source scanning probe analysis software Gwyddion (http://gwyddion.net/)
which could then be read by a laser lithography system.
Table 1
Deep reactive ion etching (DRIE) recipe.
Grayscale DRIE recipe: Etch selectivity: Optimised at 10:1.
Step Step time
(seconds)
Pressure
(mTorr)
RF power
(Watt)
ICP power
(Watt)
SF6
(Sccm)
C4f8
(Sccm)
O2
(Sccm)
Etch 3 10 5 300 100 5 0
O2 etch 3 10 5 300 0 0 30
Deposition 4 10 5 300 5 100 0
Repeats 80e100
Grayscale deep reactive ion etch (DRIE) recipe. SF6¼ Sulfur hexaﬂuoride.
C4F8 ¼ Octaﬂuorocyclobutane. SCCM¼ Standard cubic centimetres per minute.
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The following fabrication protocol was optimised for the particular equipment in
our facility and further details can be found in the patent application [30]. In a class
100 clean room, a 2  2 cm2 plain silicon wafer was sonicated for 5 min each in
acetone, distilled water and isopropyl alcohol (IPA), dried with nitrogen gas and
dehydrated on a hot plate set at 200 C for 10 min. Resist adhesion was promoted
using hexamethlydisilazane (HMDS) (Sigma-Aldrich, UK) which was spun onto the
wafer at 4000 RPM for 60 s. This was immediately followed by spin coating of
photoresist S1813® (Microposit® S1800® Series, Shipley, UK) onto the siliconwafer at
3000 RPM for 60 s, producing a thickness of 1.3 mm, followed by a soft bake at 72 C
for 1 min 30 s on a hot plate. Maskless grayscale photolithography was performed
using a laserwriter (Microtech Laserwriter LW405, Italy). The prepared grayscale
bitmap image was loaded into the laserwriter and the pixel size was set at 0.5 mm in
X and Y. A 40x objective and 0.65 NA was used. A baseline exposure dose of 0 J/cm2
was assigned to black pixels (pixel 0, no exposure) and a dose of 0.11 J/cm2 was
assigned to white pixels (pixel 256, maximum exposure), with corresponding doses
within this dose range assigned to each pixel according to the grayscale pattern.
Exposing the photoresist to a beam of 405 nm wavelength leads to modiﬁcation of
the molecular structure of the photoresist resulting in solubilisation of the exposed
areas (for a positive resist) in appropriate developer solution. Essentially, grayscale
level corresponds with exposure dose which corresponds with feature depth after
development. Optimisation was performed on a grayscale wedge design until
linearity of the exposed resist was achieved. The exposed resist was developed in
MF®-319 developer solution (Microposit®, Shipley, UK) for 30 s with gentle agitation
followed by 1 min in distilled water to stop the development and then dried with a
gentle stream of nitrogen gas.
2.3.4. Fabrication of master template using modiﬁed deep reactive ion etching
An Oxford Plasmalab System 100 ICP65 (Oxford Instruments, UK) deep reactive
ion etcher (DRIE) running a modiﬁed Bosch process recipe was used to permanently
transfer the exposed ADM pattern from the photoresist into the silicon wafer, which
subsequently acted as a template to produce PDMS stamps through soft lithography.
The Bosch process is a two-step time-multiplexed etching system which allows for
the transfer of deep, highly anisotropic features, through alternating deposition
(C4F8) and etching (SF6) steps. Increased isotropy and lower etch selectivity were
required for the accurate transfer of the ADM pattern, therefore, the etch selectivityTable 2
Characterisation of native acellular dermal matrix (ADM), acellular dermal matrix poly
dimethylsiloxane casted (ADM PDMS C) surface, smooth implant surface and textured im
Surface Sa (nm) Sq (nm) Sz (nm) Sv (nm)
Mean ± Mean ± Mean ± Mean
ADM
Native
480.4 177 607.6 221.9 4020.7 1352.3 2009
ADM
PDMS F
484 187.9 550 231.6 3366 1119.4 1692
ADM
PDMS C
522.7 155 664 191.3 4501.1 1205 2235
Smooth 22.2 9.6 36.1 22.3 483 258.4 144
Textured 8240 4760 10,000 5800 40,002 20,900 20,060
Both ADM PDMS F and ADM PDMS C surfaces were accurately fabricated and possessed sim
C surface contained more of the features of native ADM, and was a more reliable fabricati
the ADM PDMS F surface. The native ADM, ADM PDMS F and ADM PDMS C surfaces all ha
Smooth silicone implant surfaces contained nano-scale peak surface irregularities, which
implants are macroscopically nodular, surfaces containing Sz values in excess of 40 mm. T
dimension of both smooth and textured implants was approximately 2. Data is displayed a
standard deviation. (Sa¼ arithmetical mean height; Sq ¼ root mean square height; Sz ¼m
height; Ssk ¼ skewness; excess Sku ¼ kurtosis e 3, FD¼ Fractal dimension).was signiﬁcantly reduced to 10:1 through the addition of an oxygen only step to a
recipe containing optimised pressures, gases, RF and ICP power, cycle time and re-
peats. The modiﬁed DRIE parameters can be found in Table 1.2.3.5. Soft lithography used to create biomimetic silicone surfaces from master
template
The PDMS used to create ADM PDMS surfaces for biological evaluation was
kindly donated by Mentor Corporation (Mentor Corporation, Texas, USA) and was
the same medical grade mixed dimethyl silicone elastomer dispersion used to
manufacture the company's own commercially available implant surfaces. The sili-
con master was vapour treated with a silanizing agent, Trichloro (1H, 1H, 2H, 2H-
perﬂuorooctyl) silane (FDTS) (Sigma-Aldrich, UK) for 10 min in a desiccator under
vacuum, reducing surface free energy in order to ease the release of PDMS from the
silicon master. The PDMS was spun onto the silicon wafer (100 RPM) and de-gassed
in a desiccator for 1 h to remove any bubbles and to aid the transfer of features
within the silicon template into the PDMS. To cure and crosslink the PDMS it was
baked overnight in an oven at 80 C. A 1.5  1.5 cm2 PDMS stamp containing the
fabricated surface topography of ADM was then cut out using a scalpel which could
then be used for biological evaluation.2.4. Fabrication of ADM PDMS C
The ADM PDMS C surface was fabricated through a standard soft lithography
technique. After drying at 4 C, ADM was directly silanized with FDTS as described
above. PDMS was poured directly onto native ADM and cured for 48 h at room
temperature (17 C). This was then peeled off the ADM surface to create an inverted
ADM surface in PDMS. The inverted mold was again silanized, coated with PDMS,
cured and removed to reveal a PDMS cast which was a replica of the native ADM
surface.2.5. Substrate characterisation
Commercially available smooth and textured implant surfaces, native ADM,
ADM PDMS F and ADM PDMS C surfaces were characterised using AFM, scanning
electron microscopy (SEM), optical 3D proﬁling and 3D laser scanning. Roughness
measurements and quantitative topographical data were gathered using AFM.
AFM was performed using a Bruker Dimension Icon® Atomic Force Microscope
(AFM). Samples were imaged using ScanAsyst™ Air probes (silicon nitride, nominal
k ¼ 0.4 N/m) and conducted in ScanAsyst™ mode. Peak Force Tapping™ (PFT)
amplitude was 150e100 nm, and PFT frequency was 1 kHz. Scan rate was 0.5 Hz.
Images were analysed using NanoScope Analysis® software (Bruker, UK) and ISO
25178 (Surface texture: areal, Sa) roughness analysis was performed.
Prior to SEM imaging, samples were coated with 2 nm chromium (Cr), acting as
an adhesion layer and 12 nm of gold (Au). Imaging was performed on a Carl Zeiss
ULTRA PLUS system using a working distance of 2.7 mm and EHT voltage level of
7e10 kV.
Textured implant surfaces were also measured with an optical 3D proﬁler
(Bruker Contour GT-I, UK) and 3D laser scanner as they were too rough for mea-
surement with AFM.dimethylsiloxane fabricated (ADM PDMS F) surface, acellular dermal matrix poly-
plant surface.
Sp (nm) Ssk Excess Sku Fractal
dimension
SD± Mean ± Mean ± Mean ± Mean ±
827.4 2010.9 644.2 0.01 0.32 0.03 0.49 2.33 0.05
648.2 1674 472.6 0.07 0.06 0.18 0.23 2.29 0.07
883.6 2266 407.1 0.12 0.26 0.19 0.22 2.30 0.01
114.7 339.4 155 1.95 0.77 12.62 6.22 2.06 0.09
11,088 19,420 9640 0.02 0.46 3.21 0.60 2.05 0.17
ilar topographical features as existing within native ADM. However, the ADM PDMS
on method; hence Sz, Sv and Sp values were more analogous to native ADM than to
d a mean Ssk and excess Sku value of approximately 0 and a fractal dimension of 2.3.
signiﬁcantly deviated from the mean, hence an excess Sku value of 12.62. Textured
he surface features gradually deviated from the mean and were predictable. Fractal
s themean of at least six 90 90 mm2 areas of each substrate surface and ± indicates
aximum peak to valley distance; Sv¼maximum valley depth; Sp¼maximum peak
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culture and cell cycle synchronisation
Breast derived ﬁbroblasts (BDF) were used for all studies, as they are the cells
whichwould encounter the implant surface if theywere inserted into breasts in vivo.
As ﬁbroblasts from different body sites have distinct genotypic and cytokine proﬁles,
it was important to use site speciﬁc BDFs to appreciate how the effect of implant
surface topography on cells may be realised in vivo, if used clinically [31,32].
Primary BDFs were enzymatically obtained from breast gland and connective
tissue after retrieval from patients undergoing breast reduction; using standard
methods previously described in our laboratory [33]. Brieﬂy, breast tissue was
washed thoroughly in sterile PBS, before being minced ﬁnely with a scalpel and
digested in 5% collagenase A (Roche, Mannheim, Germany) for 4 h at 37 C. After
digestion, tissue was centrifuged at 1500 RPM for 10 min, supernatant removed and
resuspended in ﬁbroblast growth media (outlined above) and incubated in T75
tissue culture plastic (TCP) ﬂasks (Corning Incorporated, USA) at 37 C in humidiﬁed
5% CO2 air. Growth media was changed every 48 h and cells passaged at 70e90%
conﬂuence. All BDFs used in the following experiments are of passage 3 or lower in
an effort to retain the cells innate genotypic and phenotypic characteristics before
they're lost due to excessive passaging [34,35].
Prior to the following experiments, cell cycle synchronisationwas performed. To
synchronise the cell cycle, ﬁbroblasts are arrested at G0/G1 stage through culture in
0.2% FBS DMEM for 24 h before time point 0.
For all experiments, cells were seeded at a density of 1  104 per well, in a 24-
well cell culture plate (Corning Incorporated, USA) and performed in triplicate. Cells
were seeded onto ADM PDMS F, ADM PDMS C, smooth implant surfaces and
textured implant surfaces. TCP and collagen type 1 coated coverslips (BD Bio-
sciences, Belgium) were used as positive controls.
2.7. Cell attachment and proliferation
Cell attachment (1e6 h) and proliferation (24 he1 week) experiments were
performed using an MTT cell viability assay (Cell proliferation Kit 1 (MTT), Roche,
Germany), as per manufacturer's instructions and measured using a micro-plate
reader at a wavelength of between 570 and 650 nm.
2.8. Cell apoptosis
Cell apoptosis was determined using the lactose dehydrogenase (LDH) enzyme
assay, as per manufacture instructions (Cytotoxicity Detection Kit, Roche, Germany)
and measured on a micro-plate reader at a wavelength of between 490 and 660 nm.
2.9. RNA extraction, cDNA synthesis and quantitative reverse transcriptase chain
reaction (qRT-PCR)
Cells were collected in TRIzol buffer (Invitrogen, UK). RNA extraction, cDNA
synthesis and qRT-PCR were carried out to manufactures instructions, using stan-
dard protocol in our laboratory and as described previously [33,36]. RNA concen-
tration and purity were analysed on a NanoDrop 2000c spectrophotometer (Thermo
Scientiﬁc, USA). RNA concentration was normalised prior to cDNA synthesis and
cDNA synthesis was carried out using qScripts cDNA synthesis kit (Quanta Bio-
sceinces, USA). qRT-PCR was performed on a LightCycler 480 machine (Roche Di-
agnostics, Germany), as described previously [33,37]. The gene expression of
proliferating cell nuclear antigen (PCNA), vinculin (VCL), collagen type 1 (COL1A1),
tumour necrosis factor alpha (TNFa), interleukin 8 (IL8), heat shock protein 60
(HSP60) and transforming growth factor beta 1 (TGFb1) were analysed (All primers
from Sigma-Aldrich, UK). Primers and probes used for qRT-PCR are shown in
Supplementary Table S5. DCT values were calculated by subtracting averaged RPL32
(reference gene) CT values from averaged CT values of target gene. Relative gene
expression levels were calculated by using 2DD CT method.
2.10. Inﬂammatory marker Multi-Analyte ELISA
At each time point, cell culture media was aspirated from the cell culture well,
centrifuged for 10 min at 2500RPM to remove any particulates and frozen at 20 C
until needed. A custom made Human Inﬂammatory Marker 96-well Multi-Analyte
ELISArray kit (Qiagen, SABiosciences, UK), which quantiﬁes 12 cytokines per plate,
was performed followingmanufactures instructions. The expression of interleukin 1
alpha (IL1A), interleukin 1 beta (IL1B), transforming growth factor beta 1 (TGFb1),
interleukin 4 (IL4), interleukin 6 (IL6), interleukin 8 (IL8), interleukin 10 (IL10),
interleukin 12 (IL12), interleukin 17A (IL17A), interferon gamma (IFNg), tumour
necrosis factor alpha (TNFa) and granulocyte macrophage colony stimulating factor
(GM-CSF) were detected. Brieﬂy, samples (50 ml) are incubated for 2 h at room
temperature (RT) with assay buffer (50 ml) and serial dilutions of the antigen stan-
dards (50 ml), followed by washing three times over 5 min with wash buffer.
Detection antibody solution (100 ml) was then added and incubated for 1 h, followed
again by three washes. Avidin-HRP (100 ml) was then added to each well and
incubated for 30 min and again washed, this time four times. This was followed by
adding Development solution (100 ml) and incubating for 15min, followed by adding
Stop solution (100 ml) and read on a micro-plate reader at a wavelength of 450 nm.After media was collected for cytokine proﬁling, cells on implant surfaces were
detached from cell substrates using 0.05% trypsin (Sigma-Aldrich, UK) and 0.2%
ethylenediaminetetraacetic acid (Sigma-Aldrich, UK) in PBS, aspirated from cell
culture well and counted using a haemocytometer so that cytokine secretion levels
could be normalised by cell number.
2.11. Immunocytochemistry
Immunocytochemistry was performed on BDF's for vinculin, F-Actin and DAPI.
Cells were ﬁxed in 10% Neutral buffered formalin (NBF) (Sigma-Aldrich, UK) for 1 h,
washed in PBS and permeabilised in 0.5% Triton-X 100 (Sigma-Aldrich, UK) for
25 min. Cells were then washed and blocked in 1% BSA for 1 h at RT on a shaker at
55RPM. After washing, cells were incubated overnight at 4 C with mouse-
monoclonal anti-vinculin primary antibody (SPM227, ab18058, Abcam, UK), at a
dilution of 1:50 in PBS. The following steps are performed in the dark. Cells are
washed with PBST (0.1% tween in PBS) and then incubated with secondary antibody
anti-mouse Alexa Fluor-488 dye (Invitrogen, UK) in a 1:200 dilution on a shaker at
55RPM for 1 h at RT, wrapped in foil. After washing in PBST, cells were incubated
with rhodamine phalloidin stain (1:200 in PBS) (Sigma-Aldrich, UK) for 45min at RT.
Cells are again washed with PBST before being incubated with 40 , 6-diamidino-2-
phenylindole (DAPI, 1:500 in PBS, Invitrogen, UK) for 15 min at RT. Surfaces were
washed with PBST, mounted with Prolong gold (Invitrogen, UK) and stored in a cold
room, wrapped in foil. Surfaces were visualised on an upright immunoﬂuorescence
microscope and images recorded. (BX51, Olympus UK Ltd).
2.12. Scanning electron microscopy
Growthmediawas removed and pre-warmed (37 C) 2% glutaraldehyde (Sigma-
Aldrich, UK) in 0.1 M sodium cacodylate buffer (Sigma-Aldrich, UK) was added and
cells were ﬁxed at RT for 30 min. The ﬁxative was then removed, cells washed in
0.1 M sodium cacodylate buffer three times over 5 min, before adding 2% osmium
(Sigma-Aldrich, UK) in distilled water for 20 min. Cells were washed again with
buffer before being dehydrated through a graded series of alcohols (30%, 50%, 70%,
90%, and 100% x 3; 10 min at each concentration), then gradually transferred
through a graded series of HMDS (Sigma-Aldrich, UK) (I.e. 100% ethanol, 30%, HMDS,
50% HMDS, 70% HMDS and 100% HMDS; 10 min at each stage). The samples are then
left to dry in a fume hood overnight before Cr/Au (~15 nm) was deposited by E-beam
evaporation and the sample was visualised.
2.13. Statistical analysis
All experiments were performed three times, in triplicates. All statistical tests
were performed using GraphPad Prism 6 software. Relative optical density (OD)
values of the colourimetric MTT/LDH assays were used for cell attachment, cell
proliferation and cell survival comparisons. To determine the difference in gene
expression between BDFs on different surfaces the relative threshold cycle (CT) was
used, obtained from PCR. Relative gene expressionwas calculated using the 2DD CT
method and used for comparison. Normalised optical density values of the col-
ourimetric ELISA cytokine array were used for cytokine level comparisons. Two-way
ANOVA followed by Turkey post-hoc multi-comparison analysis was performed for
all experiments and a p value of less than 0.05 was considered as statistically
signiﬁcant.
3. Results
3.1. Presence of intact basement membrane on ADM surface after
decellularisation
After removal of the epidermis and decellularisation of the
dermis, immunoperoxidase staining for collagen type IV, collage
type VII and laminin V revealed that the dermal basement mem-
brane was intact (Supplementary Fig. S2CeE). Furthermore, H&E
revealed morphology of the dermis was preserved throughout the
decellularisation process (Supplementary Fig. S2AeB).
3.2. Substrate characterisation
Areal 3D surface analysis revealed comprehensive differences in
topography and roughness values between ADM and commercially
available implant surfaces, as summarised in Table 2. Textured
implant surfaces (Sa ¼ 8.24 mm; Sz ¼ 40 mm) were ~17 times
rougher than ADM (Sa¼ 0.48 mm; Sz¼ 4 mm) and around 400 times
rougher than smooth implant surfaces (Sa ¼ 0.022 mm;
Sz ¼ 0.48 mm). ADM was found to be a gradually undulating, self-
similar surface, containing macro, micro and nano-scale features
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Fig. 2. A comparison of native acellular dermal matrix (ADM) topography and roughness (A) with acellular dermal matrix polydimethylsiloxane fabricated surface (ADM PDMS F)
(B) and acellular dermal matrix polydimethylsiloxane cast surface (ADM PDMS C) (C) to analyse the accuracy of the respective fabrication methods of reproducing ADM topography
in silicone. Two dimensional (2D) atomic force microscopy (AFM) images are shown in (i) and the corresponding three dimensional (3D) image is shown in (ii). Section proﬁles of 2D
images in (i) (indicated by white dashed line) are shown in (iii). Scanning electron microscopy (SEM) images are displayed in (iv). Comparing native ADM (A) and ADM PDMS F (B) it
is clear to see the accurate reproduction of topographical features and roughness of ADM into silicone using the novel 3D grayscale fabrication technique. The casting technique to
prepare ADM PDMS C (C) was, however, slightly more accurate at reproducing the topographical features of ADM, as shown in the SEM images (iv).
D.J.T. Kyle et al. / Biomaterials 52 (2015) 88e102 93(Fig. 1A iev). A skewness and excess kurtosis value of approxi-
mately 0 indicates a surface which contains a Gaussian distribution
of peaks and troughs, which do not signiﬁcantly deviate from the
mean. Smooth silicone implant surfaces are predominantly ﬂat
surfaces with positive skewness and excess kurtosis values, indi-
cating a surface with many random small nanoscale peaks on the
surface which signiﬁcantly deviate from the mean (Fig. 1B iev).
Textured silicone implant surfaces were found to be extremely
rough, nodular surfaces with features several hundreds of microns
large, and SEM revealed minimal texturing at the micro and
nanoscale (Fig. 1C iev). A positive skewness and negative excess
kurtosis indicates a predominance of peaks, which vary gradually
and predictably from the mean.3.3. Characterisation of ADM PDMS F and ADM PDMS C surfaces
ADM PDMS F and ADM PDMS C surfaces were also characterised
and compared with native ADM, to evaluate the accuracy with
which each fabrication technique reproduced ADM features and is
also summarised in Table 2. Both fabrication techniques were ableFig. 1. Surface characterisations of native acellular dermal matrix (ADM) (A), commercially a
surface image of a 90  90 mm2 atomic force microscopy (AFM) scan of ADM (A) and smooth
of a textured implant (C) is shown in (i), while (ii) is a section proﬁle through ﬁgure (i) as
90  90 mm2 AFM scan of ADM (A), smooth implant surface (B) and a three dimensional (3D)
(iii). Figures (iv) and (v) are scanning electron microscopy (SEM) images of each surface. Tak
containing a complex, hierarchical micro and nanoscale topography while commercially avai
and micro-scale surface irregularities and textured silicone mammary implant surfaces are m
areas between these steep nodules are smooth. (Scale bar (iv) ¼ 100 magniﬁcation; (v) ¼to reproduce ADM topography and roughness in PDMS accurately
(Fig. 2AeC) but the direct casting technique of native ADM most
reliably reproduced features and is considered the gold standard
technique to create biomimetic topographies (Fig. 2Cieiv). Both
techniques were able tomimic features down to 10's of nanometres
in scale. It can be seen in the SEM images in Fig. 2A (iv) and 2B (iv)
that although the maskless grayscale lithography technique was
able to accurately reproduce features at the micro and nanoscale,
the undulating features of native ADM at the macro scale were
missed, as these were out of the Z range of the AFM scanner and
were therefore not included in the grayscale montage which was
used to create the ADM PDMS F surface.3.4. ADM PDMS topography promoted increased cell attachment
after 6 h
As seen in Fig. 3A, attachment of BDFs to ADM PDMS F was
signiﬁcantly greater after 4 h than to smooth (p ¼ 0.0051) and
textured (p ¼ 0.0005) implant surfaces. After 6 h, there was a
signiﬁcantly increased BDF attachment to both ADM PDMS F and Cvailable smooth (B) and textured (C) silicone implant surfaces. A two dimensional (2D)
implant surface (B) and a 1 1 cm2 two dimensional (2D) laser scanning surface image
indicated by the line white dashed line. A three dimensional (3D) surface image of a
laser scanning image of a 1 1 cm2 scan of the textured implant surface (C) is shown in
en together, these images and measurements reveal that ADM is an undulating surface
lable smooth silicone implant surfaces are predominantly ﬂat but contain random nano
acroscopically rough, nodular surfaces with regular features over 200 mm in height. The
1000 magniﬁcation).
Fig. 3. Breast derived ﬁbroblast (BDF) attachment, proliferation and survival were enhanced on acellular dermal matrix (ADM) polydimethylsiloxane (PDMS) surfaces. Breast-
derived ﬁbroblast (BDF) attachment (A) was measured between 1 and 6 h. Signiﬁcantly increased BDF attachment on acellular dermal matrix polydimethylsiloxane fabricated
and casted (ADM PDMS F and C) surfaces was observed at 6 h. BDF proliferation (B) and apoptosis (C) on respective silicone surfaces was measured at 24 h, 48 h, 96 h and 1 week.
BDF proliferation and survival were both signiﬁcantly enhanced by ADM PDMS F and C surfaces, in comparison to smooth and textured silicone implant surfaces from 48 h and
continuing up to 1 week. Tissue culture plastic (TCP) and collagen were used as controls. Data is expressed as mean ± SD of three independent experiments, performed in triplicate
and analysed using two-way ANOVA (* ¼ p < 0.05).
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ADM PDMS C p ¼ 0.037) and textured (ADM PDMS F p < 0.0001;
ADM PDMS C p¼ 0.0012) implant surfaces. Furthermore, there was
no signiﬁcant difference between cell attachment on both smooth
and textured implant surfaces after 6 h, and no signiﬁcant differ-
ence between ADM PDMS C and ADM PDMS F surfaces.
3.5. Cell proliferation was promoted on ADM PDMS surfaces up to 1
week
As seen in Fig. 3B, after 24 h, signiﬁcantly increased cell prolif-
eration was observed on ADM PDMS F surfaces in comparison to
smooth (p ¼ 0.046) and textured implant surfaces (p ¼ 0.032). By
48 h there was a noticeable increase in proliferation of BDFs on
ADM PDMS F and C surfaces in comparison to smooth and textured
implant surfaces which became most signiﬁcant after 1 week (after
1 week, ADM PDMS F vs. smooth p ¼ 0.03; vs. textured
p¼< 0.0001; ADM PDMS C vs. smooth p¼< 0.0001; vs. textured
p¼< 0.0001). Moreover, after 1 week, there was a signiﬁcantly
increased BDF proliferation on smooth implant surfaces in com-
parison to textured implant surfaces (p ¼ 0.042) and signiﬁcantly
increased proliferation of BDFs on ADM PDMS C surface in com-
parison to the ADM PDMS F surface (p ¼ 0.048).
3.6. ADM PDMS topography promoted increased cell survival at
every time point
As seen in Fig. 3C, LDH assay revealed improved BDF survival on
ADM PDMS surfaces at every time point, in comparison to smoothand textured silicone implant surfaces. This was most signiﬁcant
after 96 h and continued up to 1 week (at 1 week, ADM PDMS F vs.
smooth p < 0.0001; vs. textured p < 0.0001; ADM PDMS C vs.
smooth p < 0.0001; vs. textured p < 0.0001). In addition, increased
cell death was observed in BDFs cultured on textured implant
surfaces in comparison to smooth implant surfaces after 1 week
(p ¼ 0.0011). Furthermore, at 1 week there was signiﬁcantly
increased cell survival of BDFs on ADM PDMS C surface in com-
parison to ADM PDMS F surface (p ¼ 0.028).
3.7. ADM PDMS induced a positive alteration in gene expression
associated with attachment, proliferation, ECM synthesis and
inﬂammation
As seen in Fig. 4A, after 24 h, PCNA was signiﬁcantly up-
regulated in BDFs on ADM PDMS F surfaces and by 96 h PCNA
was signiﬁcantly up-regulated in BDFs on both ADM PDMS F and C
surfaces in comparison to smooth and textured implant surfaces
(ADM PDMS F vs. smooth p ¼ 0.036; vs. textured p ¼ 0.0010; ADM
PDMS C vs. smooth p ¼ 0.0013; vs. textured p < 0.0001). There was
no signiﬁcant difference in PCNA mRNA expression between BDF
on ADM PDMS F or ADM PDMS C surfaces (p > 0.05). Vinculin was
signiﬁcantly up-regulated on ADM PDMS surfaces after 24 h which
continued up to 1 week, as seen in Fig. 4B (At 1 week, ADM PDMS F
vs. smooth p < 0.0001; vs. textured p ¼ 0.008; ADM PDMS C vs.
smooth p < 0.0001; vs. textured p < 0.0001). Furthermore, there
was no signiﬁcant difference between vinculin gene expression in
BDFs cultured on ADM PDMS F, in comparison to ADM PDMS C (1
week, p ¼ 0.55), or between smooth and textured implant surfaces
Fig. 4. Acellular dermal matrix (ADM) polydimethylsiloxane (PDMS) topography induced alteration in genes associated with attachment, proliferation, ECM synthesis and
inﬂammation. Relative gene expression of PCNA (A), vinculin (B), IL8 (C), TNF-alpha (D), TGF-beta 1 (E), Collagen 1 (F) and HSP60 (G) of breast-derived ﬁbroblasts (BDFs) on silicone
surfaces from 24 h up to 1 week. Acellular dermal matrix polydimethylsiloxane fabricated and casted topographies (ADM PDMS F and C) induced up-regulation of PCNA, vinculin
and collagen 1 in BDFs while IL8, TNF-a, TGF-b and HSP60 were down-regulated, in comparison to BDFs on smooth and textured silicone implant surfaces. Tissue culture plastic
(TCP) and collagen were used as controls. mRNA expression was normalised by reference gene RPL32. Data is expressed as mean ± SD of three independent experiments, performed
in triplicate and analysed using two-way ANOVA (* ¼ p < 0.05).
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regulated in BDFs after 24 h on ADM PDMS surfaces in compari-
son to smooth and textured implant surfaces, as seen in Fig. 4C
(ADM PDMS F vs. smooth p < 0.0001; vs. textured p < 0.0011; ADM
PDMS C vs. smooth p < 0.0001; vs. textured p ¼ 0.0002), which
continued up to 48 h for BDFs on ADM PDMS C surfaces in com-
parison to smooth implant surfaces (ADM PDMS C vs. smooth
p ¼ 0.026). Moreover, there was a signiﬁcant down-regulation of
IL8 in BDFs cultured on textured implant surfaces in comparison to
BDFs on smooth implant surfaces after 24 h (p¼ 0.0074). As seen in
Fig. 4D, TNFa was signiﬁcantly down-regulated in BDFs on ADM
PDMS surfaces in comparison to smooth implant surfaces only after
24 h (p¼< 0.05). However, after 48 h TNFawas signiﬁcantly down-
regulated in BDFs on ADM PDMS surfaces in comparison to both
smooth and textured silicone implant surfaces (After 48 h, ADM
PDMS F vs. smooth p < 0.0001; vs. textured p < 0.0001; ADM PDMS
C vs. smooth p < 0.0001; vs. textured p < 0.0001). TGFb1 wasFig. 5. Acellular dermal matrix (ADM) polydimethylsiloxane (PDMS) topography reduced
Inﬂammatory cytokine proﬁle of breast-derived ﬁbroblasts (BDFs) on respective silicone su
control. The secretion of a number of pro-inﬂammatory cytokines (In particular IL6, IL8, and
fabricated and casted surfaces (ADM PDMS F and C) in comparison to smooth and textured s
inﬂammatory cytokine proﬁle to a pro-ﬁbrotic cytokine proﬁle in BDFs on smooth and tex
surfaces. Conversely, at 96 h, an increase in the secretion of IL10 by BDFs on ADM PDMS F and
Data is expressed as mean ± SD of three independent experiments, performed in triplicate
implant surface; # ¼ p < 0.05 in comparison to textured silicone implant surface).signiﬁcantly down-regulated in BDFs on ADM PDMS surfaces after
96 h in comparison to smooth implant surfaces and in comparison
to both smooth and textured implant surfaces by one week, as seen
in Fig. 4E (At one week, ADM PDMS F vs. smooth p < 0.0001; vs.
textured p ¼ 0.031; ADM PDMS C vs. smooth p < 0.0001; vs.
textured p < 0.0001). Furthermore, at one week, TGFb1 was
signiﬁcantly up-regulated in BDFs on smooth implant surfaces in
comparison to textured implant surfaces (p ¼ 0.0002). As seen in
Fig. 4F, collagen type 1 was up-regulated in BDFs on ADM PDMS
surfaces in comparison to smooth and textured implant surfaces
after 48 h (ADM PDMS F vs. smooth p ¼ 0.0036; vs. textured
p < 0.001; ADM PDMS C vs. smooth p < 0.002; vs. textured
p < 0.005). By 96 h, collagen type 1 was only up-regulated in BDFs
on ADM PDMS C surfaces in comparisons to textured surfaces
(p ¼ 0.009). By one week there was no difference in expression of
collagen 1 in BDFs on any of the silicone surfaces. HSP60was down-
regulated in BDFs on ADM PDMS surfaces in comparison to smoothbreast derived ﬁbroblast (BDF) pro-inﬂammatory and pro-ﬁbrotic cytokine secretion.
rfaces at 24 h (A), 48 h (B), 96 h (C) and 1 week (D). Tissue culture plastic (TCP) was a
TNF-alpha) were decreased by BDFs on acellular dermal matrix polydimethylsiloxane
ilicone implant surfaces, at each time point. At 96 h, there was a transition from a pro-
tured silicone implant surfaces which was attenuated by BDFs on ADM PDMS F and C
C surfaces may indicate a switch from a pro-inﬂammatory to pro-wound healing state.
and analysed using two-way ANOVA (* ¼ p < 0.05 in comparison to smooth silicone
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smooth and textured implant surfaces by 96 h, which continued up
to one week, as seen in Fig. 4G (At one week, ADM PDMS F vs.
smooth p ¼ 0.0037; vs. textured p < 0.0001; ADM PDMS C vs.
smooth p < 0.0001; vs. textured p < 0.0001). Furthermore, HSP60
was down-regulated in BDFs on smooth implant surfaces in com-
parison to textured implant surfaces (p¼< 0.0001).
3.8. ADM PDMS topography reduced breast derived ﬁbroblast pro-
inﬂammatory and pro-ﬁbrotic cytokine secretion
The secretion of a number of pro-inﬂammatory cytokines by
BDFs on ADM PDMS F and ADM PDMS C surfaces was reduced in
comparison to both smooth and textured implant surfaces, indi-
cating that ADM topography was able to attenuate the acute in vitro
foreign body response of BDFs to the silicone surface, up to a 1week
time point. At 24 and 48 h, the secretion of IL6, IL8, and TNFa by
BDFs on ADM PDMS surfaces were reduced in comparison to
smooth and textured implant surfaces while TGFb1 was reduced in
comparison to smooth implant surfaces only (Fig. 5A). In addition,
by 48 h, IL1A, IL17A and GM-CSF secretion by BDFs on ADM PDMS C
were also reduced and secretion of IL10 was increased, in com-
parison to BDFs on textured implant surfaces only. Furthermore,
secretion of IFNgwas reduced by BDFs on both ADM PDMS C and F
surfaces in comparison to smooth and textured implant surfaces
(Fig. 5B). At 96 h, the observed mitigated pro-inﬂammatory
response of BDFs to ADM PDMS surfaces was most prominent
and a reduced secretion of IL1A, IL6, IL8, IL12, IL17A, IFNg, TNFa,
TGFb and GM-CSF by BDFs was observed in comparison to BDFs on
smooth and textured silicone implant surfaces, which continued up
to one week (Fig. 5C). Moreover, at 96 h, a transition from a pro-
inﬂammatory weighted cytokine proﬁle to a pro-ﬁbrotic
weighted cytokine proﬁle of BDFs on smooth and textured
implant surfaces may have been taking place, highlighted through
an increase in TGFb1 secretion by BDFs on smooth and textured
implant surfaces, which peaked at one week (Fig. 5D). Conversely,
increased secretion of the anti-inﬂammatory and pro-wound
healing cytokine IL10 by BDFs on ADM PDMS surfaces was
observed at 1 week in comparison to BDFs on smooth and textured
surfaces, in addition to the reduced secretion of the aforemen-
tioned pro-inﬂammatory and pro-ﬁbrotic cytokines (Fig. 5D).
Together these results indicate that a topographically induced
reduction in pro-inﬂammatory cytokine secretion and enhanced
pro-wound healing cytokine secretion by BDFs on ADM PDMS
surfaces was observed, which was most signiﬁcant after 96 h. After
this time, a switch from a pro-inﬂammatory cytokine proﬁle to a
pro-ﬁbrotic cytokine proﬁle in BDFs on smooth and textured
implant surfaces and to an anti-inﬂammatory/pro-wound healing
proﬁle in BDFs on ADM PDMS F and C surfaces was detected.
3.9. Immunocytochemistry and SEM imaging revealed increased
focal contact formation and spindle shaped BDF morphology of
breast derived ﬁbroblasts on ADM PDMS surfaces
As seen in Fig. 6AeD, immunoﬂuorescence images revealed
speciﬁc focal staining of vinculin in BDFs on ADM PDMS surfaces.
The formation of focal contacts at the tips of F-actin ﬁlaments is
characteristic of focal adhesions indicating that BDFs on ADMPDMS
surfaces can form stable attachment to the underlying biomimetic
topography, and subsequently spread to develop typical ﬁbroblast
“spindle like” morphology. SEM images (Fig. 7AeD) demonstrated
attachment of BDFs to speciﬁc features on the ADM PDMS surfaces
indicating that the ADM topography provided topographical cues
which the cells were able to sense and interact with. As seen in
Fig. 6EeF, immunoﬂuorescence staining of BDFs on smooth implantsurfaces revealed round cell morphology, containing diffuse and
non-speciﬁc vinculin stainingwith no focal contact formation. BDFs
have aggregated on the surface of the smooth implant and are often
seen preferentially binding to each other instead of forming focal
contacts with the underlying implant surface topography. SEM
imaging (Fig. 7EeF) conﬁrmed the poor attachment and spherical
shape of BDFs on smooth implant surfaces. BDFs on textured
implant surfaces also revealed mostly diffuse and non-speciﬁc
staining of vinculin and minimal focal contact formation, with a
signiﬁcant number of cells appearing to be trapped in deep troughs
between nodules (Fig. 6GeH). However, some focal adhesions were
clearly observed but were difﬁcult to demarcate. The cells were able
to spread; however, as shown in Fig. 7GeH, it appears that the cells
are wedged within the valleys between the steep nodules on the
textured implant surface. Taken together, the immunoﬂuorescence
and SEM images suggest that BDFs on textured implant surfaces
were unable to spread or migrate effectively due to physical re-
striction by the steep nodule side walls present within the textured
surface and also displayed rounded morphology due to lack of
micro and nanoscale topographies.
4. Discussion
This study, for the ﬁrst time, demonstrates that ADM surface
topography, accurately replicated in silicone using a novel fabri-
cation technique (not previously reported), induces improved
breast ﬁbroblast cell attachment, proliferation, survival and
diminished acute in vitro foreign body response to silicone,
compared to breast ﬁbroblasts seeded onto commercially available
smooth and textured silicone implant surfaces. Extensive charac-
terisation of native ADM in addition to smooth and textured
implant surfaces revealed a number of signiﬁcant topographical
and roughness differences between surfaces whichmay explain the
enhancement in cell response to ADM PDMS surfaces. Textured
implant surfaces were found to be extremely rough, nodular sur-
faces at themacro scale (features>200 mm) but, similarly to smooth
implant surfaces, are relatively uniform at the microscale and
nanoscale. Therefore, although textured implant surfaces un-
doubtedly inﬂuence tissue response in vivo, they have little impact
on cellular response, as the textured features are too large to be
recognised by a cell's ﬁlopodia and lamellipodia. This is in contrast
to the fractal, self-similar, nano andmicroscale topography of ADM,
which contains a range of hierarchical features, all within the size
range of features that a cell is able to sense, interact with and
respond to. Clinically, a silicone surface containing ADM topo-
graphical cues, may facilitate cell adaptation but would not be too
rough (macroscopically) or porous, as to encourage excessive tissue
in growth which may aggravate the local micro-environment and
lead to seroma formation, which has been associated with textured
implant surfaces [38].
Therefore, the rationale behind this work was to reproduce
ADM's range of complex features in silicone, in an attempt to
enhance silicone biocompatibility through biomimetic topography.
Thus, the ﬁrst important outcome was the optimisation of a fabri-
cation technique which enabled reproducible, accurate replication
of biomimetic topographies in silicone. We were able to achieve
this through an innovative technique combining the use of AFM, 3D
grayscale lithography and modiﬁed DRIE. As shown in Table 2,
comprehensive areal (S) roughness analysis of fabricated surfaces
revealed that the optimised fabrication technique was able to
accurately reproduce nano and micro-scale features of ADM in
silicone to within 10 nm (Native ADM Sa ¼ 480 nm; ADM PDMS F
Sa ¼ 484 nm). Furthermore, ADM PDMS F peak to valley mea-
surements were within 0.6 mm of native ADM (Native ADM
Sz¼ 4 mm; ADM PDMS F Sz¼ 3.4 mm) while skewness, kurtosis and
Fig. 6. Immunocytochemistry revealed increased focal contact formation of breast derived ﬁbroblasts (BDFs) on acellular dermal matrix (ADM) polydimethylsiloxane (PDMS)
surfaces. Immunoﬂuorescence staining of breast-derived ﬁbroblasts (BDFs) on acellular dermal matrix polydimethylsiloxane fabricated (ADM PDMS F) (AeB), acellular dermal
matrix polydimethylsiloxane casted (ADM PDMS C) (CeD), smooth silicone implant surfaces (EeF) and textured silicone implant surfaces (GeH). The images show staining of F-
Actin (red), vinculin (green) and DAPI (blue). Insets in B and D show focal contact formation of BDFs on ADM PDMS surfaces (White scale bar ¼ 40 magniﬁcation). White arrows
are pointing to focal contacts. Cells on ADM PDMS F and C surfaces (AeD) were able to attach, form visible focal contacts and spread, revealing typical ‘spindle-like’ ﬁbroblast
morphology. This is in stark contrast to BDFs on smooth silicone implant surfaces (EeF) which attached poorly and demonstrated preferential cellecell attachment than cell-
substrate attachment, which can be indicative of stressed/frustrated cell behaviour. Similarly, BDFs on textured implant surfaces (GeH) also demonstrated poor cell attachment
but some focal contact formation was observed. Interestingly, BDFs on textured silicone implant surfaces appeared to be ‘trapped’ within the deep troughs on the implant surface
and adhered to the steep nodule side walls.
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AFM rendering, section proﬁles and SEM images revealed precise
reproduction of ADM topography, in addition to roughness. For
corroboration of the topographical effects of ADM PDMS F on cell
response, a second silicone surface (ADM PDMS C) was prepared
through a standard soft lithography (replica moulding) technique,
which has been demonstrated to reproduce features accurately at a
nanoscale [39]. The ADM PDMS C surface was found to have
reproduced the features of native ADM at the macro, micro and
nanoscale. Together, the two novel ADM PDMS surfaces permitted
the robust investigation of BDFs to ADM topography in silicone.ADM PDMS surfaces promoted increased BDF attachment, pro-
liferation and cell survival in comparison to smooth and textured
silicone implant surfaces, at every time point up to one week. Cell
attachment of BDFs was increased on ADM PDMS surfaces in the
MTT cell viability assay, through measurement of mRNA transcrip-
tion levels of vinculin and immunoﬂuorescence staining of vinculin
proteinwithin focal adhesions. Vinculin is amembrane-cytoskeletal
protein and an essential component of focal adhesions formed be-
tween cells and their environment [40]. Its function is important for
cell attachment, spreading, migration, proliferation and differenti-
ation [41]. For adherent cells, such as ﬁbroblasts, optimum cell
Fig. 7. Scanning electron microscopy (SEM) images revealed speciﬁc attachment of breast derived ﬁbroblasts (BDFs) to topographical features on acellular dermal matrix (ADM)
polydimethylsiloxane (PDMS) surfaces and spindle shaped BDF morphology. Scanning electron microscopy (SEM) images of breast-derived ﬁbroblasts (BDFs) on acellular dermal
matrix polydimethylsiloxane fabricated (ADM PDMS F) (AeB), acellular dermal matrix polydimethylsiloxane casted (ADM PDMS C) (CeD), smooth implant surfaces (EeF) and
textured implant surfaces (GeH). Insets show focal contact formation of BDFs to speciﬁc topographical features on ADM PDMS surfaces (A and D); while cells are round and poorly
spread on smooth and textured surfaces (F and H). (Black scale bars in A, C, E, G ¼ 400 magniﬁcation, in B, D, F, H ¼ 1000magniﬁcation and insets ¼ 4000 magniﬁcation in
(B), 6000 magniﬁcation in (D) and 2000 magniﬁcation in (F) and (H). The borders of BDFs on ADM PDMS surfaces are highlighted with a yellow dashed line to clearly demarcate
cells. Black arrows point to cells attached to silicone surface. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
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with surrounding ECM (or prosthesis topography) [42]. This is
because focal contacts are critical to mechanotransduction path-
ways (the mechanism through which cells convert mechanical cues
within their extracellular environment into alteration of gene and
protein expression) [43]. The formation of tissue or substrate spe-
ciﬁc focal contacts results in appropriately activated mechano-
transduction pathways (ErK, JNK, FAK) which alter cell function and
control cell fate [44,45]. Hence, the following alterations in gene
expression and cytokine secretion begins with cell attachment to
substrata via focal contacts and therefore the ability of ADM PDMSsurfaces to promote enhanced cell adhesion is fundamental to the
success of the surface as a biomaterial. Equally, BDF proliferation
was found to be increased on ADM PDMS surfaces through MTT cell
viability assay and qRT-PCR for the PCNA gene. PCNA becomes
highly expressed during DNA synthesis and repair [46]. Prolifer-
ating cells are metabolically active and constantly synthesising new
DNA prior to mitosis and therefore PCNA is an indication of these
processes [47]. As mRNA transcription does not always result in
corresponding protein translation, the MTT cell viability assay
conﬁrmed that an increase in cell proliferation (protein level) was
indeed promoted by ADM PDMS topographies and validated the
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a measurement of cell survival as LDH is released into cell culture
media by cells that have undergone apoptosis. Improved cell sur-
vival of BDFs on ADM PDMS surfaces was observed via reduced LDH
levels in cell culture media and is consistent with the cell prolifer-
ation and immunoﬂuorescence data.
Our results are consistent with the paradigm that cellular
functions such as attachment, proliferation and survival can be
inﬂuenced by underlying substrate topographies, independent of
surface chemistry, as it has been shown previously that cells are
able to respond to numerous silicone geometries of various di-
mensions, down to 10 nm in height [48]. However, there have been
few in vitro studies which have attempted to mimic basement
membrane or ECM topography in silicone and the majority of
previous studies were performed on arbitrary, periodic, non-
variant topographies such as grooves, pits or pillars, with mini-
mal consideration for mimicking a cell's in-vivo niche microenvi-
ronment [49]. Nonetheless, there is a body of evidence to which
this work adds to, such as the ﬁnding that biomimetic intestinal
crypt-like topography in PDMS was found to enhance Caco-2 cell
metabolic activity [50] and bioengineered limbal crypts in collagen
hydrogels regulated limbal epithelial stem cell differentiation [51].
Furthermore, engineered hydrogel skeletal muscle architecture
enabled highly differentiated myoﬁber formation [52]. Recently, an
engineered “off the shelf” heart valvewasmanufactured, which has
yet to be biologically evaluated beyond cell viability assays, but may
signiﬁcantly improve long-term valve performance, as a major
limitation of currently available valve replacement's is leaﬂet
ﬁbrosis [53]. In this work we found that at bothmRNA transcriptionFig. 8. A schematic illustration is proposed as a hypothetical mechanism for enhanced c
dimethylsiloxane (ADM PDMS) topography in comparison to BDFs on smooth and textured
levels, BDFs on ADM PDMS surfaces displayed improved cellular attachment to underlying
focal contacts in immunoﬂuorescence stained images (1). The formation of stable focal con
function. Therefore, the formation of speciﬁc, conformational, focal contacts, directed by A
ronment to the nucleus via various mechanotransduction pathways (2). We evidenced that
controlling cell attachment, proliferation, inﬂammation and ECM deposition (3). Furthermor
level through attenuation of the secretion of a number of pro-inﬂammatory and pro-ﬁbrotic
together, this in vitro study found ADM PDMS F and C surfaces were able to promote cell att
foreign body reaction of BDFs to silicone surfaces in comparison to smooth and textured imp
sensing regulate cell functions. Nat Rev Mol Cell Biol. 2006; 7:265e75. Adapted from: Vogel
Biol. 2006; 7:265e75.and protein translation levels, the secretion of pro-inﬂammatory/
pro-ﬁbrotic cytokines IL8, TNFa and TGFb1 were reduced by BDFs
on ADM PDMS surfaces in comparison to smooth and textured
implant surfaces. IL8 and TNFa are acute phase inﬂammatory
chemokines and cytokines, respectively, and have been associated
with inﬂammatory conditions such as rheumatoid arthritis, psori-
asis, cystic ﬁbrosis and pulmonary ﬁbrosis [54,55]. TGFb1 is a pro-
ﬁbrotic cytokine which has been implicated in the formation of
ﬁbrotic disorders such as hypertrophic scarring, keloid scarring and
Dupuytrens contracture/disease via transformation of ﬁbroblasts
into myoﬁbroblasts and their persistence within tissue beyond
normal physiological time scales [56]. Signiﬁcantly, IL8, TNFa and
TGFb have all been found to be up-regulated in contracted ﬁbrotic
breast capsules around commercially available silicone implants
[57e59]. Therefore, it is particularly relevant that ADM PDMS to-
pographies were found to down-regulate these pro-inﬂammatory/
pro ﬁbrotic mediators at both mRNA transcription and protein
levels, in comparison to commercially available smooth and
textured implant surfaces. HSP60 is a genewhich is up-regulated in
stressed cells [60]. It has been identiﬁed within the peri-implant
protein milieu, in association with contracture formation [61]. It
was found to be down-regulated in BDFs on ADM PDMS surfaces,
which may indicate that cells are less stressed on ADM PDMS
surfaces in comparison to their response to commercially available
silicone implant surfaces.
At 48 h, collagen type 1 was found to be up-regulated in BDFs on
ADMPDMS surfaces in comparison to smooth and textured implant
surfaces, which returned to baseline levels by one week. In agree-
ment with our work, nanoscale topographies on low-adhesionellular response of breast derived ﬁbroblast (BDFs) on acellular dermal matrix poly-
silicone implant surfaces. As ascertained at mRNA transcription and protein translation
ADM PDMS topography which was clearly visualised through vinculin staining within
tacts is critical to mechanotransduction pathways, which are potent mediators of cell
DM topographical cues, enables BDFs to convey messages of their surrounding envi-
this ‘activation’ of mechanotransduction pathways resulted in the alteration of genes
e, we found that this alteration in mRNA transcription levels were realised at a protein
cytokines, in addition to increased secretion of pro-wound healing cytokines (4). Taken
achment, proliferation and survival of BDFs, in addition to mitigating the acute in vitro
lant surfaces. Schematic inspired by Vogel and Sheetz (2006). Local force and geometry
V, Sheetz M. Local force and geometry sensing regulate cell functions. Nat Rev Mol Cell
D.J.T. Kyle et al. / Biomaterials 52 (2015) 88e102 101substrates (as PDMS inherently is) have been found to up-regulate
collagen 1 expression as a result of improved cell attachment [62].
It follows that if cells are able to form stable focal adhesions with
underlying substrata, which promotes metabolic activity, ﬁbro-
blasts will proliferate and begin to synthesise, degrade and remodel
collagens at the surfaceecell interface, as they would within native
ECM. However, although early up-regulation of collagen 1 was
induced in BDFs on ADM PDMS surfaces, to understand how this
may relate to peri-implant capsule formation, it is imperative in
future work to measure deposition of collagen and other ECM
proteins on the substrate surface, in addition to analysis of the
levels of matrix metalloproteinases (MMPs), tissue inhibitors of
metalloproteinases (TIMPs) and collagenases. As secretion of TGFb1
was not increased by BDFs on ADM PDMS surfaces, we hypothesise
that the up-regulation of collagen type 1 mRNA transcription was
not due to interaction with the TGFb1 receptor and activation of
SMAD signalling pathways but may be due activation of mecha-
notransduction pathways via integrins [63].
Normalised cytokine proﬁling revealed the attenuation of a
number of inﬂammatory cytokines by BDFs on ADM PDMS surfaces
in comparison to smooth and textured implant surfaces. Although
the pathogenesis of capsular contracture appears to be multifac-
torial, an acute inﬂammatory response against the implant surface
seems central to its formation and contracture rates have been
found to correlate positively with levels of inﬂammation [64].
Moreover, Wolfram (2012) found that dysregulated intracapsular
regulatory T cells and a TH1/TH17 weighted immune response may
lead to excessive ﬁbrosis and contracture formation. The authors
detected increased levels of the pro-inﬂammatory cytokines IL6,
IL8, IL17, IFNg and TGFb1 in the media of isolated intracapsular T
cells, which may have been contributing to capsular contracture
progression [65]. As the secretion of these same cytokines were
reduced by BDFs on ADM PDMS surfaces, ADM topography in sili-
cone may potentially avert the in vivo progression from capsule
formation to contracture through mitigation of the inﬂammatory
response towards the silicone implant surface.
Taken together, the evidence demonstrated in this work con-
ﬁrms that ADM PDMS topographical cues induce alteration of
mRNA transcription and protein translation levels of a number of
keymediators of the acute foreign body response to silicone (Fig. 8).
This is in agreement with Chen et al. (2010) that found nano and
micron scale topography could affect foreign body response of
macrophages in comparison to planar controls [66]. In addition, our
work corresponds with the results in Yanez-Soto et al. (2013) that
demonstrated corneal epithelial wound healing was enhanced on
biomimetic basement membrane topography in comparison to ﬂat
controls [67]. However, to ascertain whether the positive, in vitro
effects of ADM topography have the potential to alter the long term
in vivo foreign body response to silicone was beyond the scope of
this study. Despite our promising ﬁndings, it is acknowledged that
these results are purely the outcome of in vitro studies and there-
fore it is crucial that long term clinical studies in animals or humans
are performed to uncover the true performance of this biomimetic
surface and analysis of the in vivo response would be highly
recommended.
5. Conclusion
Biomimetic silicone topographies were successfully engineered
through a novel 3D grayscale fabrication technique, which repre-
sents a useful strategy to generate surfaces capable of signiﬁcantly
enhancing silicone implant surface performance. Silicone surfaces
functionalised with ADM topography induced speciﬁc responses in
breast-derived ﬁbroblasts, which resulted in attenuation of the
acute in vitro foreign body reaction to surfaces for up to one week.This data indicates that ADM topography may induce activation of
mechanotransduction pathways through the formation of speciﬁc
focal contacts with biomimetic surface features, which leads to
down-regulation of pro-inﬂammatory/pro-ﬁbrotic genes in addi-
tion to the reduced secretion of pro-inﬂammatory/pro-ﬁbrotic cy-
tokines. Biomimetic topographies require considerable
consideration in the pursuit to enhance biocompatibility of current
implant surfaces. In particular, engineered silicone mammary
implant surfaces containing biomimetic ADM topography may
potentially lead to reduced rates of capsular contracture formation
and further work should seek to evaluate functional performance in
an in vivo model.
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